Offers

Discussion in 'Aimmune' started by anonymous, Jul 24, 2019 at 8:38 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Contingent offers are a big risk. Good candidates will get multiple job offers and have to decide whether they want to wait for Aimmune’s FDA Advisory Board Meeting. I think this strategy will backfire. They should consider bringing highly desired talent or talent in key markets on early (LA, SF, NY, TX, CHI, FL, ATL, etc). There’s no reason top markets shouldn’t have PAM’s working in the field doing premarket work.

    The ICER report is negative and demonstrates a lack of understanding of the purpose of OIT. Most ICER reports are negative, but allergists and payers understand the importance of this therapy. OIT is VERY important for a lot of patients, particularly pediatric patients. 2-3 million people have peanut allergies and a drug that can offer some desensitization and minimize life threatening risks is a win for the patient. This is a great opportunity, however the conservative approach means they might lose some good field talent.

    Good luck to all of you who are interviewing and looking forward to August panel interviews.
     

  2. anonymous

    anonymous Guest

    Conservative approach? The company was originally only bringing 40 on in Sept, now they are bringing all 80. The drug isn't getting approved till January at best. They are doing prework.
     
  3. anonymous

    anonymous Guest

     
  4. anonymous

    anonymous Guest

    Yes, conservative! PAM's should be working major markets NOW!!!
     
  5. anonymous

    anonymous Guest

    Many have received offers and openings are being filled fast.
     
  6. anonymous

    anonymous Guest

    False.
     
  7. anonymous

    anonymous Guest

    Has anyone had the final call with R. Smith and received an offer after the Chicago interviews this week?
     
  8. anonymous

    anonymous Guest


    Heard several offers are out, but I am still waiting for the offer, maybe the offers are not accepted?
     
  9. anonymous

    anonymous Guest

    Go away gay janitor
     
  10. anonymous

    anonymous Guest

    Any offers in AZ?
     
  11. anonymous

    anonymous Guest

    I heard interviewing goes through today
     
  12. anonymous

    anonymous Guest

    What sort of signing bonuses are we talking?
     
  13. anonymous

    anonymous Guest

    8000 shares. One firm just put target price at $79 per share. Could get rich here.
     
  14. anonymous

    anonymous Guest

    With peanut flour?
     
    SWxSW likes this.
  15. anonymous

    anonymous Guest

    RIght. Delusional post. Doctors are already doing their own OIT. This stock won't go to 79.
     
  16. anonymous

    anonymous Guest

    Yes, some doctors are doing OIT by trial and error with varying degrees success- w/o insurance coverage.

    You see how this is different, don’t you? Smarten up buttercup!
     
  17. anonymous

    anonymous Guest

    Haha $79 pps. you sure you didn't mean $7.90 pps? No way this takes off. The treatment is just not efficacious enough to warrant the every 2 week visit, in which it will be uncomfortable for the patient. Its like going to the dentist every 2 weeks. You think people would like going to the dentist every 2 weeks for 6 months? haha
     
  18. anonymous

    anonymous Guest

    Buttercup is smart. Allergist in territory I interviewed for has desensitized 800 patients to date. Takes the ‘trial and error’ off the table. Might want to check this out if considering offer.
     
  19. anonymous

    anonymous Guest

    Sorry you didn’t get an offer.

    I checked with a pediatric allergist at a major academic medical center. This is going to be BIG! I can’t wait...
     
  20. anonymous

    anonymous Guest

    8000 shares or 8000 options?